Annual FCF
-$97.69 M
-$39.51 M-67.91%
December 31, 2023
Summary
- As of February 7, 2025, EWTX annual free cash flow is -$97.69 million, with the most recent change of -$39.51 million (-67.91%) on December 31, 2023.
- During the last 3 years, EWTX annual FCF has fallen by -$82.86 million (-558.44%).
- EWTX annual FCF is now -944.73% below its all-time high of -$9.35 million, reached on December 31, 2019.
Performance
EWTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$27.89 M
-$1.57 M-5.98%
September 30, 2024
Summary
- As of February 7, 2025, EWTX quarterly free cash flow is -$27.89 million, with the most recent change of -$1.57 million (-5.98%) on September 30, 2024.
- Over the past year, EWTX quarterly FCF has dropped by -$5.38 million (-23.89%).
- EWTX quarterly FCF is now -915.07% below its all-time high of -$2.75 million, reached on March 31, 2020.
Performance
EWTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$110.10 M
-$5.38 M-5.14%
September 30, 2024
Summary
- As of February 7, 2025, EWTX TTM free cash flow is -$110.10 million, with the most recent change of -$5.38 million (-5.14%) on September 30, 2024.
- Over the past year, EWTX TTM FCF has dropped by -$24.25 million (-28.25%).
- EWTX TTM FCF is now -3906.55% below its all-time high of -$2.75 million, reached on March 31, 2020.
Performance
EWTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
EWTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -67.9% | -23.9% | -28.3% |
| 3 y3 years | -558.4% | -23.9% | -28.3% |
| 5 y5 years | -944.7% | -23.9% | -28.3% |
EWTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -185.9% | at low | -193.7% | +3.5% | -222.2% | at low |
| 5 y | 5-year | -944.7% | at low | -915.1% | +3.5% | -3906.6% | at low |
| alltime | all time | -944.7% | at low | -915.1% | +3.5% | -3906.6% | at low |
Edgewise Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$27.89 M(+6.0%) | -$110.10 M(+5.1%) |
| Jun 2024 | - | -$26.32 M(-8.9%) | -$104.72 M(+5.4%) |
| Mar 2024 | - | -$28.89 M(+7.1%) | -$99.39 M(+1.7%) |
| Dec 2023 | -$97.69 M(+67.9%) | -$26.99 M(+19.9%) | -$97.69 M(+13.8%) |
| Sep 2023 | - | -$22.52 M(+7.3%) | -$85.85 M(+12.0%) |
| Jun 2023 | - | -$20.99 M(-22.8%) | -$76.63 M(+5.8%) |
| Mar 2023 | - | -$27.19 M(+79.5%) | -$72.43 M(+24.5%) |
| Dec 2022 | -$58.18 M | -$15.15 M(+14.0%) | -$58.18 M(+10.8%) |
| Sep 2022 | - | -$13.29 M(-20.9%) | -$52.53 M(+9.6%) |
| Jun 2022 | - | -$16.80 M(+29.8%) | -$47.95 M(+17.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$12.94 M(+36.2%) | -$41.00 M(+20.0%) |
| Dec 2021 | -$34.17 M(+130.3%) | -$9.50 M(+9.0%) | -$34.17 M(+16.6%) |
| Sep 2021 | - | -$8.71 M(-11.5%) | -$29.32 M(+22.8%) |
| Jun 2021 | - | -$9.85 M(+60.9%) | -$23.88 M(+31.2%) |
| Mar 2021 | - | -$6.12 M(+31.9%) | -$18.21 M(+22.7%) |
| Dec 2020 | -$14.84 M(+58.7%) | -$4.64 M(+41.5%) | -$14.84 M(+45.5%) |
| Sep 2020 | - | -$3.28 M(-21.4%) | -$10.20 M(+47.4%) |
| Jun 2020 | - | -$4.17 M(+51.9%) | -$6.92 M(+151.9%) |
| Mar 2020 | - | -$2.75 M | -$2.75 M |
| Dec 2019 | -$9.35 M | - | - |
FAQ
- What is Edgewise Therapeutics annual free cash flow?
- What is the all time high annual FCF for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual FCF year-on-year change?
- What is Edgewise Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly FCF year-on-year change?
- What is Edgewise Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Edgewise Therapeutics?
- What is Edgewise Therapeutics TTM FCF year-on-year change?
What is Edgewise Therapeutics annual free cash flow?
The current annual FCF of EWTX is -$97.69 M
What is the all time high annual FCF for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual free cash flow is -$9.35 M
What is Edgewise Therapeutics annual FCF year-on-year change?
Over the past year, EWTX annual free cash flow has changed by -$39.51 M (-67.91%)
What is Edgewise Therapeutics quarterly free cash flow?
The current quarterly FCF of EWTX is -$27.89 M
What is the all time high quarterly FCF for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly free cash flow is -$2.75 M
What is Edgewise Therapeutics quarterly FCF year-on-year change?
Over the past year, EWTX quarterly free cash flow has changed by -$5.38 M (-23.89%)
What is Edgewise Therapeutics TTM free cash flow?
The current TTM FCF of EWTX is -$110.10 M
What is the all time high TTM FCF for Edgewise Therapeutics?
Edgewise Therapeutics all-time high TTM free cash flow is -$2.75 M
What is Edgewise Therapeutics TTM FCF year-on-year change?
Over the past year, EWTX TTM free cash flow has changed by -$24.25 M (-28.25%)